MYRIAD GENETICS INC Quarterly Unrecognized Tax Benefits in USD from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Myriad Genetics Inc quarterly Unrecognized Tax Benefits history and growth rate from Q2 2010 to Q4 2023.
  • Myriad Genetics Inc Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $48.1M, a 9.57% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $48.1M +$4.2M +9.57% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $43.9M +$11.8M +36.8% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $27.9M -$4.1M -12.8% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $27.7M -$3.3M -10.6% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $28M -$2.8M -9.09% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $32.1M -$5.5M -14.6% Dec 31, 2021 10-K 2024-02-28
Q3 2021 $32M -$5.4M -14.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $31M +$7.5M +31.9% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $30.8M +$8.5M +38.1% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $37.6M +$15.2M +67.9% Dec 31, 2020 10-K 2024-02-28
Q3 2020 $37.4M +$15.3M +69.2% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $23.5M +$1.8M +8.3% Jun 30, 2020 10-K 2023-03-01
Q1 2020 $22.3M +$2.4M +12.1% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $22.4M -$2.5M -10% Dec 31, 2019 10-Q 2020-02-07
Q3 2019 $22.1M -$2.5M -10.2% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $21.7M -$3.2M -12.9% Jun 30, 2019 10-K 2023-03-01
Q1 2019 $19.9M -$8M -28.7% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $24.9M -$8.5M -25.4% Dec 31, 2018 10-Q 2019-02-06
Q3 2018 $24.6M -$7.3M -22.9% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $24.9M -$300K -1.19% Jun 30, 2018 10-K 2022-02-25
Q1 2018 $27.9M +$3M +12% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $33.4M +$8.8M +35.8% Dec 31, 2017 10-Q 2018-02-07
Q3 2017 $31.9M +$7.5M +30.7% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $25.2M +$1.2M +5% Jun 30, 2017 10-KT 2021-03-16
Q1 2017 $24.9M +$900K +3.75% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $24.6M -$3.3M -11.8% Dec 31, 2016 10-Q 2017-02-08
Q3 2016 $24.4M -$2.8M -10.3% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $24M -$2.4M -9.09% Jun 30, 2016 10-K 2017-08-09
Q1 2016 $24M -$2.11M -8.09% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $27.9M +$2.57M +10.2% Dec 31, 2015 10-Q 2016-02-03
Q3 2015 $27.2M +$2.69M +11% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $26.4M +$2.2M +9.09% Jun 30, 2015 10-K 2016-08-10
Q1 2015 $26.1M +$12.5M +91.4% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $25.3M +$12M +90.2% Dec 31, 2014 10-Q 2015-02-04
Q3 2014 $24.5M +$12.2M +98.4% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $24.2M +$13.5M +126% Jun 30, 2014 10-K 2015-08-12
Q1 2014 $13.6M +$3.16M +30.2% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $13.3M +$3.18M +31.4% Dec 31, 2013 10-Q 2014-02-05
Q3 2013 $12.4M +$2.22M +21.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $10.7M +$710K +7.09% Jun 30, 2013 10-K 2014-08-13
Q1 2013 $10.5M +$470K +4.7% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $10.1M +$690K +7.3% Dec 31, 2012 10-Q 2013-02-06
Q3 2012 $10.1M +$690K +7.3% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $10M +$360K +3.73% Jun 30, 2012 10-K 2013-08-14
Q1 2012 $10M +$560K +5.93% Mar 31, 2012 10-Q 2012-05-02
Q4 2011 $9.45M +$128K +1.37% Dec 31, 2011 10-Q 2012-02-01
Q3 2011 $9.45M +$648K +7.36% Sep 30, 2011 10-Q 2011-11-02
Q2 2011 $9.65M +$848K +9.64% Jun 30, 2011 10-K 2012-08-15
Q1 2011 $9.45M Mar 31, 2011 10-Q 2011-05-04
Q4 2010 $9.32M Dec 31, 2010 10-Q 2011-02-01
Q3 2010 $8.8M Sep 30, 2010 10-Q 2010-11-03
Q2 2010 $8.8M Jun 30, 2010 10-K 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.